Transwarp Technology (Shanghai) Co (688031) Fair Value & Analysis
Technology · CN · Market cap 15.6B CNY
Analysis
Transwarp Technology (Shanghai) Co (688031) currently trades at ¥124.06, while our model-based Fair Value estimate is ¥21.36 — implying the stock looks roughly 82.8% overvalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Transwarp Technology (Shanghai) Co.,Ltd. provides infrastructure software and services for integration, storage, governance, modeling, analysis, mining, and circulation in China and internationally. The company offers Transwarp Data Hub, a big data infrastructure platform; a big data cloud platform, including Transwarp Data Cloud, a Transwarp cloud operating system; Transwarp ArgoDB, a self-developed distributed analytical database; Transwarp KunDB, a distributed transactional database; Transwarp Data Studio, a platform for big data development and governance; Transwarp Sophon, an intelligent analysis tool; and Transwarp Knowledge Hub, an AI infrastructure platform, as well as big data and intelligent recognition appliance series products, such as TxData and TxIRA. It also provides data lake, data mart, data warehouse, digital innovation platform, edge computing, machine leaning, and information retrieval solutions. The company serves financial, transportation, energy, government, e…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.